Voltaren Arthritis Pain Gel: OTC relief for stiff and aching joints

Responsible: ad hoc news Lifestyle & Consumer Desk. Reviewed prior to publication on June 12, 2026 at 1:33 PM ET. Details in the imprint.

Voltaren Arthritis Pain Gel is one of the most visible consumer-health brands linked to GSK PLC through its former consumer business, now Haleon, and it continues to stand out as an over-the-counter option for adults seeking targeted arthritis pain relief without a prescription. The U.S. Food and Drug Administration approved Voltaren Arthritis Pain Gel (diclofenac sodium topical gel 1%) for over-the-counter use in early 2020, and it became broadly available on U.S. retail shelves later that year. Marketed in the United States by Haleon, which was spun off from GSK in 2022, the gel remains a flagship nonprescription nonsteroidal anti-inflammatory drug (NSAID) for osteoarthritis pain in joints such as hands, wrists, elbows, knees, ankles, and feet. For consumers comparing options at pharmacies or online retailers, the product offers a familiar prescription-strength active ingredient in a topical format designed for repeated daily use.

What Voltaren Arthritis Pain Gel does and how it works

Voltaren Arthritis Pain Gel contains 1% diclofenac sodium, an NSAID that works by inhibiting cyclooxygenase enzymes involved in the production of prostaglandins, which play a key role in inflammation and pain signaling. Unlike oral NSAIDs that circulate systemically, the gel is meant to deliver the active ingredient directly through the skin to the affected joint tissues, offering local pain relief with lower systemic exposure when used as directed. The product is indicated in the U.S. for the temporary relief of arthritis pain in specific joints in adults 18 years and older, including hands, wrists, elbows, knees, ankles, and feet, but not for use on the spine, hips, or shoulders. The label states that users should apply the gel four times daily to affected joints, using the dosing card included in the package to measure the correct amount of product per application. As with other topical NSAIDs, the directions also emphasize not using more than the recommended total daily dose and limiting use to no more than 21 days unless directed by a doctor.

The prescription heritage of diclofenac sodium is a central part of Voltaren Arthritis Pain Gel's positioning in the aisle. Before the U.S. switched the product to over-the-counter status, diclofenac sodium gel was available only by prescription for osteoarthritis pain in joints like the knees and hands. The switch decision followed an evaluation of safety and efficacy data, including clinical studies showing that diclofenac 1% gel can reduce osteoarthritis pain intensity when applied as directed over several weeks. The topical route offers an alternative for adults who may not tolerate oral NSAIDs well or who prefer to avoid additional systemic medication on top of their existing prescriptions. According to publicly available information from Haleon, Voltaren Arthritis Pain Gel is fragrance-free and non-greasy, factors that matter for day-to-day adherence when a product must be applied multiple times per day. For shoppers comparing competing topical arthritis products, this combination of prescription-derived active ingredient, clear dosing instructions, and a long-standing brand name is a key differentiator in the category.

U.S. availability is broad: Voltaren Arthritis Pain Gel is sold in major drugstores, mass merchants, grocery chains, and online retailers including Amazon.com, Walmart, Target, CVS, Walgreens, and other pharmacy chains. Typical package sizes in the U.S. market include 1.7 oz, 3.5 oz, and 5.3 oz tubes, with suggested prices varying by retailer and any ongoing promotion. For example, online listings in 2026 often show the 3.5 oz size in a price range around $15 to $25, depending on the seller and discounts on a given day. Because over-the-counter pricing can change frequently due to promotions, loyalty programs, and third-party sellers, shoppers generally see real-time prices at the point of purchase rather than a uniform national MSRP. The product sits in the same shelf space as other topical pain relievers such as menthol-based gels, lidocaine creams, capsaicin products, and competing diclofenac gels, but its arthritis-specific branding and dosing card help signal that it is meant for chronic joint pain rather than general muscle aches. Adults using the product are directed to rub it gently into the affected area, avoid covering with bandages or heating pads, and wash their hands after applying the gel to a joint other than the hands.

Safety labeling for Voltaren Arthritis Pain Gel follows the pattern of other NSAID-based products, including warnings about potential cardiovascular and gastrointestinal risks associated with systemic exposure to NSAIDs, even though topical use typically leads to lower blood levels than oral forms when used as directed. The Drug Facts label advises users not to use the product together with other NSAIDs, whether oral or topical, unless directed by a doctor, and not to apply to wounds, infections, or damaged skin. People with a history of allergic reactions to aspirin or other NSAIDs are instructed to avoid the gel. The label also recommends consulting a health professional before use in individuals with conditions such as high blood pressure, heart disease, liver disease, kidney disease, or stomach bleeding history, reflecting classwide NSAID precautions. From a consumer standpoint, the need to apply the gel four times per day may require some planning, especially for those balancing work and caregiving responsibilities, but the gel format avoids the need to swallow tablets or capsules and can be integrated into morning and evening routines.

Since Haleon was separated from GSK in 2022 as a standalone consumer health company, Voltaren Arthritis Pain Gel has been reported as part of Haleon's Pain Relief category, which includes several analgesic brands targeting different use cases. Public presentations from Haleon have highlighted Voltaren as one of its global power brands, citing strong positions in key markets such as the U.S. and Europe. For GSK PLC, which now focuses on biopharmaceuticals and vaccines, Voltaren illustrates the type of mature consumer brand that moved into the Haleon portfolio while GSK sharpened its prescription-drug and vaccine strategy. GSK PLC's sponsored American depositary receipts trade on the New York Stock Exchange under the ticker GSK, and shares of GSK PLC (GB0009252882, ticker GSK) closed at $52.91 on NYSE on June 11, 2026.

This article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.